Compounds > clindamycin

clindamycin and Parkinson Disease

clindamycin has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aschhoff, S; Endres, S; Müller-Felber, W; Remien, J; Schroff, KC; Schulze, J; Toepfer, M1

Other Studies

1 other study(ies) available for clindamycin and Parkinson Disease

ArticleYear
Clindamycin and nicotinic neuromuscular transmission.
    Lancet (London, England), 1999, Nov-20, Volume: 354, Issue:9192

    Topics: Animals; Anti-Bacterial Agents; Clindamycin; Diabetes Mellitus, Type 2; Humans; Mice; Parkinson Disease; Receptors, Muscarinic; Receptors, Nicotinic; Signal Transduction; Synaptic Transmission

1999